Source - SMW
OptiBiotix Health said it had an abstract accepted for presentation at ProBiota 2018 in Barcelona from February 7 to 9.

ProBiota is an annual event for the global prebiotic, probiotic and microbiome-focused food and pharma industries.

The abstract reports on the identification and development of a prebiotic that selectively enhances the growth of Lactobacillus rhamnosus GG in the gut.


At 9:41am: (LON:OPTI) Optibiotix Health Plc share price was +1.5p at 65.5p